Antiaging Quantum Living INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OID
Antiaging Quantum Living Inc. files its annual 10-K report, detailing a strategic shift towards proprietary health products and therapy services, alongside financial performance and operational updates.
OID
Antiaging Quantum Living Inc. (AAQL) reported a dramatic increase in revenue for the fiscal year ended March 31, 2025, driven by new technical support services, but continues to face substantial net losses and a going concern warning.
OID
Antiaging Quantum Living Inc. has filed an amendment to its annual report to include an omitted auditor's report, while also disclosing material weaknesses in its internal controls and a going concern assessment.
OID
Antiaging Quantum Living Inc. reports a net loss of $412,971 for the fiscal year ended March 31, 2024, amidst a strategic shift towards global markets and the establishment of new subsidiaries.